A global study investigating the safety and effectiveness of a new tablet form of weight loss medication has found it resulted in meaningful weight loss.

A trio of pioneering review papers published in The Lancet that offer fresh perspectives on cardiometabolic multiple long-term conditions (MLTCs or multimorbidity) has been unveiled on the international stage.

Current thinking around type 2 diabetes remission needs to be re-examined to improve patient outcomes, researchers behind a ground-breaking new report have said.